US Broker Ratings

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Exploring a 21.08% Potential Upside

Smith & Nephew SNATS, Inc. (NYSE: SNN) is a prominent player in the healthcare sector, specifically within the medical devices industry. Headquartered in Watford, United Kingdom, this venerable company, founded..

Fresenius Medical Care AG (FMS) Stock Analysis: Assessing a 24.54% Potential Upside for Investors

Fresenius Medical Care AG (NYSE: FMS), headquartered in Bad Homburg, Germany, stands as a prominent player in the healthcare sector, specifically in the medical care facilities industry. With a market..

GE HealthCare Technologies (GEHC) Stock Analysis: Uncovering a 25.96% Potential Upside

As GE HealthCare Technologies Inc. (NYSE: GEHC) navigates the dynamic landscape of the healthcare sector, investors are keeping a close watch on the company’s stock performance and growth potential. With..

Novo Nordisk A/S (NVO) Stock Analysis: Unveiling Growth Potential with a 3.91% Dividend Yield

Novo Nordisk A/S (NVO), a titan in the healthcare sector, is widely recognized as a formidable player in the global pharmaceutical landscape. With its headquarters in Bagsvaerd, Denmark, the company..

BioNTech SE (BNTX) Stock Analysis: Exploring a 37.9% Potential Upside Amidst Biotech Challenges

BioNTech SE (NASDAQ: BNTX) has made headlines as a frontrunner in biotechnology, notably with its mRNA vaccine for COVID-19. However, beyond the past successes, investors are now keen to understand..

Tenet Healthcare Corporation (THC) Stock Analysis: Exploring a 28.97% Potential Upside

Tenet Healthcare Corporation (NYSE: THC) presents a compelling case for investors seeking exposure in the healthcare sector, particularly in the medical care facilities industry. With a market capitalization of $16.4..

Exelixis, Inc. (EXEL) Stock Analysis: Strong Revenue Growth and Promising Pipeline Drive Investor Interest

Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology industry, is attracting attention in the healthcare sector due to its robust revenue growth and an impressive product pipeline aimed..

Incyte Corporation (INCY): Investor Outlook with a Promising 10% Upside Potential

Incyte Corporation (NASDAQ: INCY) stands out as a compelling investment opportunity in the biopharmaceutical sector, particularly for investors eyeing potential growth in the healthcare industry. With a market capitalization of..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: A Deep Dive into Valuation Insights and Growth Potential

Dr. Reddy’s Laboratories Ltd (NYSE: RDY) continues to position itself as a formidable player in the global healthcare sector. With a market capitalization of $11.05 billion, Dr. Reddy’s operates predominantly..

Cigna Group (CI) Stock Analysis: Potential Upside and Analyst Consensus Signal Promising Growth

The Cigna Group (NYSE: CI), a titan in the healthcare plans industry, presents an intriguing opportunity for investors seeking exposure to a robust sector. With its roots dating back to..

GSK plc (GSK) Stock Analysis: Evaluating a 14.37% Upside Potential in the Healthcare Sector

Investors seeking opportunities in the healthcare sector may find GSK plc (NYSE: GSK) an intriguing proposition. As a stalwart in the global pharmaceutical landscape, GSK’s extensive portfolio in vaccines and..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Exploring a 25% Upside Potential with Robust Revenue Growth

Investors looking to capitalize on burgeoning opportunities in the healthcare sector may want to keep a close eye on Neurocrine Biosciences, Inc. (NBIX). With a market capitalization of $15.31 billion,..

Danaher Corporation (DHR) Stock Analysis: Potential 46% Upside Amid Strong Buy Ratings

Danaher Corporation (NYSE: DHR) stands as a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $121.14 billion, Danaher operates a..

The Cooper Companies, Inc. (COO) Stock Analysis: Unveiling a 51.78% Potential Upside in Healthcare Investments

The Cooper Companies, Inc. (NYSE: COO), a prominent player in the healthcare sector, specifically in the medical instruments and supplies industry, presents an intriguing investment opportunity with a notable potential..

Humana Inc. (HUM): Investor Outlook Reveals Revenue Growth and Analyst Ratings Amidst Potential Downside

As Humana Inc. (NYSE: HUM) continues to navigate the complex landscape of healthcare plans, investors are taking a closer look at the company’s financial health and market position. With a..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Exploring a 28% Potential Upside in the Healthcare Sector

Intuitive Surgical, Inc. (NASDAQ: ISRG) stands as a pioneering force in the healthcare sector, specifically within the medical instruments and supplies industry. With a robust market capitalization of $159.39 billion,..

Edwards Lifesciences (EW) Stock Analysis: Exploring a Robust Healthcare Investment with 21.5% Upside Potential

Edwards Lifesciences Corporation (NYSE: EW) stands as a formidable entity within the healthcare sector, specializing in innovative medical devices for cardiovascular disease treatment. With a market capitalization of $46.04 billion,..

Genmab A/S (GMAB) Stock Analysis: Unpacking the 42% Upside Potential

For investors eyeing the biotechnology sector, Genmab A/S (GMAB) presents a compelling opportunity with a potential upside of 42.01%. With its roots firmly planted in Denmark, this innovative company is..

Penumbra, Inc. (PEN) Stock Analysis: Navigating a 12.76% Upside in the Medical Devices Sector

As Penumbra, Inc. (NYSE: PEN) continues to carve out its niche in the dynamic healthcare sector, investors are keenly watching its performance. With a market capitalization of $12.67 billion, this..

Universal Health Services, Inc. (UHS) Stock Analysis: Poised for a 31% Upside with Strategic Healthcare Expansion

Universal Health Services, Inc. (NYSE: UHS), a prominent player in the healthcare sector, has captured investor attention with its potential upside of 31.39%, as indicated by analyst ratings. With a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds